{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:42:26Z","timestamp":1789756946578,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Searchlight Pharma Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00192-025-06473-8","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:50:54Z","timestamp":1765371054000},"page":"1989-1996","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Failure Rate, Time to Failure, and Associated Risk Factors: Polyacrylamide Hydrogel Injection for the Treatment of Stress Urinary Incontinence in a Large Cohort"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8730-213X","authenticated-orcid":false,"given":"Erin","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Yearwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alykhan","family":"Rajwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Sanaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Batara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"3","key":"6473_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13697137.2018.1543263","volume":"22","author":"I Milsom","year":"2019","unstructured":"Milsom I, Gyhagen M. The prevalence of urinary incontinence. Climacteric. 2019;22(3):217\u201322.","journal-title":"Climacteric"},{"key":"6473_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0828-2","volume":"15","author":"R Riemsma","year":"2017","unstructured":"Riemsma R, Hagen S, Kirschner-Hermanns R, Norton C, Wijk H, Andersson K, et al. Can incontinence be cured? A systematic review of cure rates. BMC Med. 2017;15:63.","journal-title":"BMC Med"},{"issue":"25","key":"6473_CR3","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1056\/NEJMcp1914037","volume":"384","author":"JM Wu","year":"2021","unstructured":"Wu JM. Stress incontinence in women. N Engl J Med. 2021;384(25):2428\u201336.","journal-title":"N Engl J Med"},{"issue":"6","key":"6473_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00192-009-0850-9","volume":"20","author":"M Serati","year":"2009","unstructured":"Serati M, Salvatore S, Uccella S, Artibani W, Novara G, Cardozo L, et al. Surgical treatment for female stress urinary incontinence: what is the gold standard procedure? Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(6):619\u201321.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"3","key":"6473_CR5","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/nau.23924","volume":"38","author":"SM Hussain","year":"2019","unstructured":"Hussain SM, Bray R. Urethral bulking agents for female stress urinary incontinence. Neurourol Urodyn. 2019;38(3):887\u201392.","journal-title":"Neurourol Urodyn"},{"key":"6473_CR6","first-page":"299","volume":"11","author":"C Chapple","year":"2019","unstructured":"Chapple C, Dmochowski R. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence. Res Rep Urol. 2019;11:299\u2013310.","journal-title":"Res Rep Urol"},{"key":"6473_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejogrb.2014.03.033","volume":"178","author":"A Martan","year":"2014","unstructured":"Martan A, Masata J, Svabik K, Krhut J. Transurethral injection of polyacrylamide hydrogel (Bulkamid) for the treatment of female stress or mixed urinary incontinence. Eur J Obstet Gynecol Reprod Biol. 2014;178:199\u2013202.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 5","key":"6473_CR8","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.5489\/cuaj.4612","volume":"11","author":"A Mamut","year":"2017","unstructured":"Mamut A, Carlson KV. Periurethral bulking agents for female stress urinary incontinence in Canada. Can Urol Assoc J. 2017;11(Suppl 5):S152-4.","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"6473_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00192-012-1834-8","volume":"24","author":"S Mohr","year":"2013","unstructured":"Mohr S, Siegenthaler M, Mueller MD, Kuhn A. Bulking agents: an analysis of 500 cases and review of the literature. Int Urogynecol J. 2013;24(2):241\u20137.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"6473_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/SPV.0000000000000385","volume":"23","author":"D Altman","year":"2017","unstructured":"Altman D, Ghilotti F, Bellocco R, Zetterstrom J, Kopp Kallner H. Transurethral polyacrylamide hydrogel injection therapy in women not eligible for midurethral sling surgery. Female Pelvic Med Reconstr Surg. 2017;23(5):318\u201323.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"3","key":"6473_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00192-015-2781-y","volume":"27","author":"AD Kasi","year":"2016","unstructured":"Kasi AD, Pergialiotis V, Perrea DN, Khunda A, Doumouchtsis SK. Polyacrylamide hydrogel (Bulkamid) for stress urinary incontinence in women: a systematic review of the literature. Int Urogynecol J. 2016;27(3):367\u201375.","journal-title":"Int Urogynecol J"},{"issue":"9","key":"6473_CR12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00192-017-3278-7","volume":"28","author":"ZA Siddiqui","year":"2017","unstructured":"Siddiqui ZA, Abboudi H, Crawford R, Shah S. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review. Int Urogynecol J. 2017;28(9):1275\u201384.","journal-title":"Int Urogynecol J"},{"key":"6473_CR13","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/nau.24589","volume":"40","author":"T Brosche","year":"2021","unstructured":"Brosche T, Kuhn A, Lobodasch K, Sokol ER. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 2021;40:502\u20138.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"6473_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00192-024-06005-w","volume":"36","author":"G Lamblin","year":"2025","unstructured":"Lamblin G, Boix S, Moret S, Nohuz E, Chene G, Hamid D. Effectiveness and safety profile of urethral bulking with Bulkamid\u00ae for stress urinary incontinence: a French multi-center cohort study. Int Urogynecol J. 2025;36(1):205\u201311.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"6473_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00192-009-1020-9","volume":"21","author":"K Stav","year":"2010","unstructured":"Stav K, Dwyer PL, Rosamilia A, Schierlitz L, Lim YN, Lee J. Risk factors of treatment failure of midurethral sling procedures for women with urinary stress incontinence. Int Urogynecol J. 2010;21(2):149\u201355.","journal-title":"Int Urogynecol J"},{"issue":"8","key":"6473_CR16","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/SPV.0000000000001548","volume":"30","author":"N Fleischmann","year":"2024","unstructured":"Fleischmann N, Chughtai B, Plair A, Hurtado E, Jacobson N, Segal S, et al. Urethral bulking. Urogynecology. 2024;30(8):667\u201382. https:\/\/doi.org\/10.1097\/SPV.0000000000001548.","journal-title":"Urogynecology"},{"key":"6473_CR17","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/nau.24388","volume":"39","author":"A Giammo","year":"2020","unstructured":"Giammo A, Geretto P, Ammirati E, Manassero A, Squintone L, Vercelli D, et al. Urethral bulking with Bulkamid: an analysis of efficacy, safety profile, and predictors of functional outcomes in a single-center cohort. Neurourol Urodyn. 2020;39:1523\u20138.","journal-title":"Neurourol Urodyn"},{"key":"6473_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/JU.0000000000000176","volume":"202","author":"M Elmelund","year":"2019","unstructured":"Elmelund M, Sokol ER, Karram MM, Dmochowski R, Klarskov N. Patient characteristics that may influence the effect of urethral injection therapy for female stress urinary incontinence. J Urol. 2019;202:125\u201331.","journal-title":"J Urol"},{"issue":"1","key":"6473_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00192-019-03917-w","volume":"31","author":"A Alas","year":"2020","unstructured":"Alas A, Martin L, Devakumar H, Frank L, Vaish S, Chandrasekaran N, et al. Anesthetics\u2019 role in postoperative urinary retention after pelvic organ prolapse surgery with concomitant midurethral slings: a randomized clinical trial. Int Urogynecol J. 2020;31(1):205\u201313.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"6473_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-021-01330-4","volume":"21","author":"BC Anglim","year":"2021","unstructured":"Anglim BC, Ramage K, Sandwith E, Brennand EA, Calgary Women\u2019s Pelvic Health Research Group. Postoperative urinary retention after pelvic organ prolapse surgery: influence of peri-operative factors and trial of void protocol. BMC Womens Health. 2021;21(1):195.","journal-title":"BMC Womens Health"},{"issue":"1","key":"6473_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00192-019-03917-w","volume":"31","author":"A Alas","year":"2020","unstructured":"Alas A, Martin L, Devakumar H, Frank L, Vaish S, Chandrasekaran N, et al. Anesthetics\u2019 role in postoperative urinary retention after pelvic organ prolapse surgery with concomitant midurethral slings: a randomized clinical trial. Int Urogynecol J. 2020;31(1):205\u201313.","journal-title":"Int Urogynecol J"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-025-06473-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-025-06473-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:52:34Z","timestamp":1784551954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-025-06473-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["6473"],"URL":"https:\/\/doi.org\/10.1007\/s00192-025-06473-8","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Society of Obstetricians and Gynecologists of Canada Annual Clinical Meeting, Ottawa, Ontario, Canada, June 8, 2023.The American Urogynecologic Association Pelvic Floor Disorder Virtual Week, Portland, Oregon, USA, October 5th 2023.","order":1,"name":"Ethics","label":"Presentation at Prior Conferences","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained through the University of Alberta Health Research Ethics Board (REB no. Pro00104206).","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Erin Kelly received the unrestricted grant from Searchlight Pharma Inc for this study.\u00a0May Sanaee serves on an AbbVie Canada advisory board and has received honorarium to speak for Lupin Pharma Canada.","order":3,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}